Among the 17 significantly downregulated genes in the durable disease control group, DCBLD2 was reported as a potential poor prognostic marker in colorectal cancer and lung cancer by stimulation of epithelial-to-mesenchymal transition [27,28]. Here, DCBLD2 is linked to lung carcinoma.